| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.33 | 3e-06 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.21 | 0.0002 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.15 | 0.0004 |